New drug target for inflammatory disease is all the RAGE

December 21, 2016
Credit: Mary Ann Liebert, Inc., publishers

Researchers have shown that Receptor for Advanced Glycation End Products (RAGE) helps to regulate a key signaling pathway known to promote both acute and chronic inflammation. The development of therapeutic drugs targeted to RAGE could be used to treat a range of inflammatory diseases such as asthma, infection, atherosclerosis, and arthritis, as described in an article in DNA and Cell Biology.

In "Receptor for Advanced Glycation End Products (RAGE) Regulates Leukotriene B4 Receptor 1 Signaling," authors Takako Ichiki Tomoaki Koga, and Takehiko Yokomizo, Juntendo University School of Medicine, Tokyo, and Kumamoto University, Kumamoto, Japan, report how they observed that RAGE binds to the leukotriene B4 receptor 1 (BLT1) receptor. This interaction between RAGE and BLT1 modifies LTB4-BLT1 signaling, which modulates the inflammatory response through its effects on cell migration.

"RAGE is an alarmin, a molecule that alerts the host of potential risks and challenges. It is induced in or diseases and promotes more inflammation," says Carol Shoshkes Reiss, PhD, Editor-in-Chief, of DNA and Cell Biology and Professor, Departments of Biology and Neural Science, and Global Public Health at New York University, NY. "By developing new drugs to block the interaction of RAGE with its receptor, in the future, there may be treatments of some aspects of these diseases."

Explore further: The beta-1 adrenergic receptor and RAGE work together to break hearts

More information: Takako Ichiki et al, Receptor for Advanced Glycation End Products Regulates Leukotriene BReceptor 1 Signaling, DNA and Cell Biology (2016). DOI: 10.1089/dna.2016.3552

Related Stories

The beta-1 adrenergic receptor and RAGE work together to break hearts

January 21, 2016
Cardiomyopathies result from a remodeling process that can be initiated by a variety of pathological stresses. Activation of the β-1 adrenergic receptor (β1AR) typically occurs in response to stress to rapidly increase ...

Researchers identify receptor to slow breast cancer metastasis

October 3, 2016
In a research study published in the journal Oncogene, scientists from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine showed that by therapeutically targeting the receptor for advanced ...

Inflammatory on and off switch identified for allergic asthma and COPD

August 1, 2013
Japanese researchers have made a new step toward understanding why—and how to stop—runaway inflammation for both chronic obstructive pulmonary disorder (COPD) and allergic asthma. In a new report appearing in the August ...

Can anti-inflammatory therapies be effective against epilepsy?

July 6, 2016
In epileptic patients, seizures lead to an increased level of inflammation-related proteins called chemokines in the brain, and systemic inflammation likely helps trigger and promote the recurrence of seizures, making inflammation ...

Rage against the disease

August 5, 2013
Imagine a world where asthma wasn't a chronic disease, rather an inconvenient illness whose first symptoms could be easily treated. This vision could one day become a reality thanks to cutting-edge research into an immune ...

Recommended for you

Targeting 'broken' metabolism in immune cells reduces inflammatory disease

July 12, 2017
The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune ...

A perturbed skin microbiome can be 'contagious' and promote inflammation, study finds

June 29, 2017
Even in healthy individuals, the skin plays host to a menagerie of bacteria, fungi and viruses. Growing scientific evidence suggests that this lively community, collectively known as the skin microbiome, serves an important ...

Inflammatory bowel disease: Scientists zoom in on genetic culprits

June 28, 2017
Scientists have closed in on specific genes responsible for Inflammatory Bowel Disease (IBD) from a list of over 600 genes that were suspects for the disease. The team from the Wellcome Trust Sanger Institute and their collaborators ...

Trials show unique stem cells a potential asthma treatment

June 28, 2017
A study led by scientists at Monash University has shown that a new therapy developed through stem cell technology holds promise as a treatment for chronic asthma.

Researchers find piece in inflammatory disease puzzle

May 23, 2017
Inflammation is the process by which the body responds to injury or infection but when this process becomes out of control it can cause disease. Monash Biomedicine Discovery Institute (BDI) researchers, in collaboration with ...

Researchers reveal potential target for the treatment of skin inflammation in eczema and psoriasis

May 22, 2017
Superficially, psoriasis and atopic dermatitis may appear similar but their commonalities are only skin deep. Atopic dermatitis, also known as eczema, is primarily driven by an allergic reaction, while psoriasis is considered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.